Pancreatic Surgery — MCQs

Pancreatic Surgery Indian Medical PG Practice Questions and MCQs

Question 251: Which of the following drugs has been found to increase survival in locally advanced pancreatic cancer?

A. Doxorubicin
B. Streptozocin
C. Gemcitabine (Correct Answer)
D. Paclitaxel

Explanation: **Explanation:** **Gemcitabine** (Option C) is the correct answer. It is a pyrimidine antimetabolite that inhibits DNA synthesis. For decades, Gemcitabine has been the cornerstone of chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma. Clinical trials demonstrated that Gemcitabine provides a significant "clinical benefit response" (improvement in pain, performance status, and weight) and a modest but statistically significant survival advantage compared to older agents like 5-Fluorouracil. **Analysis of Incorrect Options:** * **Doxorubicin (A):** An anthracycline primarily used in breast cancer, lymphomas, and sarcomas. It has minimal efficacy in pancreatic cancer and is not a standard treatment. * **Streptozocin (B):** This is an alkylating agent specifically toxic to pancreatic islet cells. While it is used in the management of **Pancreatic Neuroendocrine Tumors (PNETs)** like insulinomas, it is ineffective against the more common pancreatic adenocarcinoma. * **Paclitaxel (D):** While standard Paclitaxel is not used alone, its albumin-bound formulation (**Nab-paclitaxel**) is used *in combination* with Gemcitabine. However, as a monotherapy, it does not hold the same historical or clinical weight as Gemcitabine for survival. **High-Yield Clinical Pearls for NEET-PG:** * **First-line regimens:** For patients with good performance status, **FOLFIRINOX** (5-FU, Leucovorin, Irinotecan, and Oxaliplatin) or **Gemcitabine + Nab-paclitaxel** are the current preferred regimens, offering better survival than Gemcitabine alone. * **Radiosensitizer:** Gemcitabine also acts as a potent radiosensitizer in locally advanced cases. * **Tumor Marker:** **CA 19-9** is the most specific marker used to monitor treatment response and recurrence in pancreatic cancer.

Question 252: Which of the following is FALSE regarding carcinoma of the pancreas?

A. The most common site is the head and uncinate process.
B. Pain suggests unresectability.
C. Two-thirds of patients present with diabetes.
D. Acute pancreatitis never occurs in carcinoma of the pancreas. (Correct Answer)

Explanation: **Explanation:** **Why Option D is the correct (False) statement:** The statement that acute pancreatitis "never occurs" is incorrect. In fact, **acute pancreatitis** can be the initial clinical presentation in approximately 3–5% of patients with pancreatic carcinoma. This occurs because the tumor can obstruct the main pancreatic duct, leading to ductal hypertension and the premature activation of pancreatic enzymes within the parenchyma. In an elderly patient presenting with a first episode of "idiopathic" acute pancreatitis, malignancy must always be ruled out. **Analysis of Incorrect Options (True Statements):** * **Option A:** Approximately **65–75%** of pancreatic adenocarcinomas occur in the **head and uncinate process**. This is the most common site, often leading to early obstructive jaundice. * **Option B:** While not an absolute contraindication, **significant back pain** often indicates retroperitoneal invasion, neural plexus involvement, or advanced stage, which frequently correlates with **unresectability**. * **Option C:** Impaired glucose tolerance or **new-onset diabetes mellitus** is found in nearly **two-thirds (60-80%)** of patients. New-onset diabetes in an elderly, thin patient is a classic "red flag" for pancreatic cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Courvoisier’s Law:** In a patient with painless obstructive jaundice, a palpable gallbladder is likely due to malignancy (e.g., pancreatic head) rather than gallstones. * **Tumor Marker:** **CA 19-9** is the most specific marker (used for monitoring, not screening). * **Trousseau Sign:** Migratory thrombophlebitis associated with visceral malignancy (most commonly pancreas). * **Surgery:** Whipple’s Procedure (Pancreaticoduodenectomy) is the treatment of choice for resectable tumors of the head.

Question 253: Which of the following tests is NOT used in the diagnosis of insulinoma?

A. Fasting blood glucose
B. Xylose test (Correct Answer)
C. C-peptide levels
D. Insulin/Glucose Ratio

Explanation: **Explanation:** **Insulinoma** is the most common functional neuroendocrine tumor (NET) of the pancreas, characterized by the autonomous secretion of insulin regardless of blood glucose levels. 1. **Why Xylose test is the correct answer:** The **D-xylose test** is a diagnostic tool used to evaluate the absorptive capacity of the proximal small intestine. It is primarily used to differentiate between malabsorption caused by intestinal mucosal disease (e.g., Celiac disease) and maldigestion due to pancreatic exocrine insufficiency. It has no physiological or diagnostic relevance to insulin secretion or glucose metabolism. 2. **Analysis of incorrect options:** * **Fasting blood glucose:** This is a baseline test. Patients with insulinoma typically present with profound fasting hypoglycemia (glucose <40–50 mg/dL). * **C-peptide levels:** Insulin and C-peptide are secreted in equimolar amounts from the pancreas. High C-peptide levels during hypoglycemia confirm endogenous hyperinsulinism, helping rule out factitious insulin injection (where C-peptide would be suppressed). * **Insulin/Glucose Ratio:** In normal individuals, this ratio is <0.3. In patients with insulinoma, the ratio is typically **>0.3**, indicating inappropriate insulin secretion in the face of low glucose. **Clinical Pearls for NEET-PG:** * **Whipple’s Triad:** 1. Symptoms of hypoglycemia during fasting/exercise; 2. Low blood glucose (<50 mg/dL); 3. Relief of symptoms after glucose administration. * **Gold Standard Diagnosis:** The **72-hour supervised fast** is the most reliable test. * **Localization:** Endoscopic Ultrasound (EUS) is highly sensitive; Intraoperative Ultrasound (IOUS) is the most sensitive for intraoperative localization. * **Medical Management:** Diazoxide (inhibits insulin release) is used for symptomatic control.

Question 254: A 67-year-old woman is evaluated for obstructive jaundice. The cholangiographic findings indicate that she has a cancer of the lower end of the common bile duct. Clinical examination would most likely reveal which of the following?

A. Enlarged gallbladder (Correct Answer)
B. Shrunken gallbladder
C. Enlarged pancreas
D. Shrunken pancreas

Explanation: ### Explanation The correct answer is **A. Enlarged gallbladder**. This question tests the application of **Courvoisier’s Law**. In a patient with obstructive jaundice, if the gallbladder is palpable (enlarged), the obstruction is unlikely to be due to a gallstone. Instead, it is typically caused by a malignant growth, such as a tumor at the lower end of the common bile duct (CBD), periampullary carcinoma, or carcinoma of the head of the pancreas. **Why Option A is correct:** In malignancy-induced obstruction, the CBD is blocked gradually and completely. Since the gallbladder is healthy (not scarred by previous inflammation), it distends significantly due to the back-pressure of bile. This results in a non-tender, palpable gallbladder. **Why other options are incorrect:** * **B. Shrunken gallbladder:** This is seen in chronic cholecystitis or cholelithiasis. According to Courvoisier’s Law, if a stone causes the obstruction, the gallbladder is usually shrunken and fibrotic due to previous chronic inflammation, making it non-distensible and non-palpable. * **C & D. Enlarged/Shrunken pancreas:** While a tumor in the head of the pancreas can cause biliary obstruction, the pancreas itself is usually not clinically palpable on physical examination due to its retroperitoneal location, unless there is a massive pseudocyst or very advanced malignancy. ### NEET-PG High-Yield Pearls * **Courvoisier’s Law:** "In the presence of jaundice, a palpable gallbladder is NOT due to stones." * **Exceptions to Courvoisier’s Law (Palpable GB with stones):** Double impaction (stone in cystic duct and stone in CBD), Oriental cholangiohepatitis, and Mucocele of the gallbladder. * **Most common cause of Courvoisier sign:** Carcinoma of the head of the pancreas. * **Clinical Presentation:** Malignant obstruction typically presents as **painless, progressive jaundice**, whereas stone-induced obstruction presents with **colicky pain**.

Question 255: Increased level of 5 HLAA is present in:

A. Alkaptonuria
B. Albinism
C. Carcinoid tumor (Correct Answer)
D. Phenylketonuria

Explanation: **Explanation:** The correct answer is **Carcinoid tumor**. The question refers to **5-HIAA (5-Hydroxyindoleacetic acid)**, which is the primary end-metabolite of **Serotonin** (5-HT) metabolism. **1. Why Carcinoid Tumor is Correct:** Carcinoid tumors are neuroendocrine tumors, most commonly found in the terminal ileum or appendix. These tumors secrete excessive amounts of serotonin. Serotonin is metabolized by the enzyme monoamine oxidase (MAO) and aldehyde dehydrogenase into 5-HIAA, which is then excreted in the urine. A **24-hour urinary 5-HIAA test** is the gold standard biochemical marker for diagnosing and monitoring Carcinoid Syndrome. **2. Why Other Options are Incorrect:** * **Alkaptonuria:** Caused by a deficiency of homogentisate oxidase, leading to the accumulation of **homogentisic acid**, not 5-HIAA. It presents with dark urine and ochronosis. * **Albinism:** A defect in melanin synthesis due to a deficiency in the enzyme **tyrosinase**. It does not involve serotonin metabolism. * **Phenylketonuria (PKU):** Caused by a deficiency of **phenylalanine hydroxylase**, leading to high levels of phenylalanine and phenylpyruvic acid (phenylketones) in the urine. **3. High-Yield Clinical Pearls for NEET-PG:** * **Dietary Caution:** Patients must avoid serotonin-rich foods (bananas, walnuts, pineapples, avocados) for 72 hours before the 5-HIAA test to prevent false positives. * **Localization:** The most common site for a carcinoid tumor is the **Appendix**, but the most common site for tumors causing *Carcinoid Syndrome* is the **Ileum** (due to hepatic metastasis bypassing first-pass metabolism). * **Clinical Triad:** Flushing, Diarrhea, and Right-sided heart failure (Tricuspid insufficiency/Pulmonary stenosis). * **Treatment:** **Octreotide** (Somatostatin analogue) is used to manage symptoms.

Question 256: Ranson's scoring for acute pancreatitis includes all except?

A. Age >55 years
B. Serum AST >250 IU/dL
C. Sequestration of fluid >6 L
D. LDH >700 IU/L (Correct Answer)

Explanation: **Explanation:** Ranson’s Criteria is a clinical prediction rule used to estimate the severity and prognosis of acute pancreatitis. It assesses parameters at two time points: **at admission** and **within 48 hours** of admission. **Why Option D is correct:** In Ranson’s criteria, the threshold for **LDH (Lactate Dehydrogenase)** at admission is **>350 IU/L**. The value mentioned in the option (700 IU/L) is incorrect, making it the "except" choice. **Why the other options are incorrect (They are correct Ranson parameters):** * **Option A (Age >55 years):** This is a standard parameter assessed at admission. Advanced age is associated with poorer physiological reserve. * **Option B (AST >250 IU/L):** Aspartate Aminotransferase (AST) is a marker of hepatocellular injury often seen in severe pancreatitis; >250 IU/L is the correct cutoff at admission. * **Option C (Fluid Sequestration >6 L):** This is a critical parameter assessed within the first 48 hours. It indicates significant third-spacing and systemic inflammatory response. **High-Yield Clinical Pearls for NEET-PG:** To remember Ranson’s Criteria, use the mnemonics: 1. **At Admission (GA LAW):** **G**lucose (>200 mg/dL), **A**ge (>55), **L**DH (>350 IU/L), **A**ST (>250 IU/L), **W**BC count (>16,000/mm³). 2. **At 48 Hours (C HOBBS):** **C**alcium (<8 mg/dL), **H**ematocrit fall (>10%), **O**xygen (PaO₂ <60 mmHg), **B**UN increase (>5 mg/dL), **B**ase deficit (>4 mEq/L), **S**equestration of fluid (>6 L). *Note:* A Ranson score of <3 indicates mild pancreatitis (mortality ~1%), while a score of >6 indicates severe pancreatitis (mortality ~100% if untreated). For biliary pancreatitis, the cutoffs differ slightly (e.g., Age >70, WBC >18,000).

Question 257: Which of the following is associated with a poor prognosis in acute pancreatitis?

A. Hypocalcaemia (Correct Answer)
B. Hypercalcemia
C. Hypernatremia
D. All of the above

Explanation: **Explanation:** In acute pancreatitis, **Hypocalcaemia** is a well-recognized indicator of severe disease and poor prognosis. It is one of the key parameters included in the **Ranson Criteria** (measured at 48 hours) and the **Modified Glasgow Score**. **Why Hypocalcaemia occurs:** The primary mechanism is **saponification**. During acute pancreatitis, activated pancreatic lipases release free fatty acids from peripancreatic fat. These fatty acids bind to circulating calcium ions to form "calcium soaps" (insoluble salts) in areas of fat necrosis. A serum calcium level of **<8 mg/dL** (or <2 mmol/L) within 48 hours of admission signifies extensive necrotizing process and is associated with increased mortality. **Analysis of Incorrect Options:** * **Hypercalcemia:** While hypercalcemia is a known **etiology** (cause) of acute pancreatitis (due to calcium-induced activation of trypsinogen), it is not a prognostic marker of severity once the disease has started. * **Hypernatremia:** Sodium imbalances are not specific prognostic indicators in pancreatitis. Conversely, **Azotemia** (rising BUN) and fluid sequestration are significant prognostic markers. **NEET-PG High-Yield Pearls:** * **Ranson Criteria at 48 hours:** Remember the mnemonic **C-H-O-B-A-S** (Calcium <8, Hematocrit drop >10%, Oxygen/PaO2 <60, BUN rise >5, Base deficit >4, Sequestration of fluid >6L). * **Most common cause of death:** In the first week, it is **SIRS/Multiorgan failure**; after two weeks, it is **Sepsis** (infected pancreatic necrosis). * **BISAP Score:** A simple bedside tool (BUN, Impaired mental status, SIRS, Age >60, Pleural effusion) used for early risk stratification.

Question 258: Which is the most common site of carcinoma of the pancreas?

A. Head (Correct Answer)
B. Body
C. Tail
D. Neck

Explanation: **Explanation:** **1. Why the Head is the Correct Answer:** Carcinoma of the pancreas most frequently arises from the exocrine portion of the gland (ductal adenocarcinoma). Statistically, approximately **65% to 75%** of pancreatic cancers occur in the **head** of the pancreas. This anatomical preference is clinically significant because tumors in the head often compress the common bile duct early in the disease course, leading to the classic presentation of **painless, progressive obstructive jaundice** (Courvoisier’s Law). **2. Why Other Options are Incorrect:** * **Body (Option B):** Approximately 15% of tumors occur here. * **Tail (Option C):** Approximately 5-10% of tumors occur here. Tumors in the body and tail are often "clinically silent" for longer periods, typically presenting at an advanced stage with weight loss and pain rather than jaundice. * **Neck (Option D):** This is a small transitional zone between the head and body; primary tumors isolated strictly to the neck are relatively rare compared to the head. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common histological type:** Ductal Adenocarcinoma (>90%). * **Tumor Marker:** **CA 19-9** (primarily used for monitoring response to treatment and recurrence, not screening). * **Courvoisier’s Law:** In the presence of jaundice, if the gallbladder is palpable, the jaundice is unlikely to be due to gallstones (it points towards malignancy of the pancreatic head or periampullary region). * **Surgical Management:** The standard of care for resectable tumors of the head is **Whipple’s Procedure** (Pancreaticoduodenectomy), whereas tumors of the body/tail require a **Distal Pancreatectomy** with Splenectomy. * **Risk Factors:** Smoking (strongest environmental factor), chronic pancreatitis, and DM.

Question 259: Which of the following is the preoperative imaging study of choice for gastrinoma?

A. Magnetic resonance imaging (MRI)
B. Endoscopic ultrasound (EUS)
C. Somatostatin receptor scintigraphy (Correct Answer)
D. CT scan

Explanation: **Explanation:** The diagnosis of a gastrinoma (Zollinger-Ellison Syndrome) involves a two-step process: biochemical confirmation followed by anatomical localization. **Why Somatostatin Receptor Scintigraphy (SRS) is the Correct Answer:** Gastrinomas are neuroendocrine tumors (NETs) that overexpress **somatostatin receptors (SSTRs)**, specifically subtypes 2 and 5. **Somatostatin Receptor Scintigraphy (SRS)**, often performed as an Octreoscan, is the preoperative imaging of choice because it provides whole-body functional imaging. It is highly sensitive (70-90%) for detecting both the primary tumor and metastatic disease (especially in the liver and bones), which is crucial for determining surgical resectability. **Analysis of Incorrect Options:** * **CT Scan and MRI:** While useful for anatomical mapping and detecting large liver metastases, they have low sensitivity (often <50%) for detecting small primary gastrinomas, which are frequently located in the "Gastrinoma Triangle" and can be less than 1 cm in size. * **Endoscopic Ultrasound (EUS):** EUS is highly sensitive for tumors in the head of the pancreas but is invasive and less effective at visualizing tumors in the duodenal wall (the most common site for primary gastrinomas) or distant metastases. **High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle (Passaro’s Triangle):** Defined by the junction of the cystic/common bile duct, the junction of the 2nd and 3rd parts of the duodenum, and the neck/body of the pancreas. 90% of gastrinomas are found here. * **Modern Update:** While SRS is the traditional "choice," **68Ga-DOTATATE PET/CT** is now considered superior and is replacing SRS in advanced centers due to higher resolution. * **Rule of Thirds:** Approximately 1/3 of gastrinomas are associated with **MEN-1 syndrome** (usually multiple and in the duodenum), while 2/3 are sporadic.

Question 260: What is the most common cause of pancreatitis?

A. Alcohol consumption (Correct Answer)
B. Blockage of the ampulla of Vater by a gallstone
C. Consumption of food rich in trans fatty acids
D. None of the above

Explanation: **Explanation:** The etiology of pancreatitis varies globally; however, in the context of standard surgical textbooks (like Bailey & Love) and specific examination patterns for NEET-PG, **Alcohol consumption** is frequently cited as the most common cause of **chronic pancreatitis** and a leading cause of acute episodes. Alcohol induces pancreatitis by increasing the protein content of pancreatic secretions, leading to the formation of protein plugs that obstruct small ducts, alongside direct toxic effects on acinar cells. **Analysis of Options:** * **Option A (Correct):** Alcohol is the primary driver of chronic pancreatitis worldwide. In many clinical datasets, it also competes with gallstones as the leading cause of acute presentations. * **Option B (Incorrect):** While **Gallstones** are the most common cause of *acute* pancreatitis globally (especially in females), the question asks for the most common cause of pancreatitis in general. In many academic contexts, alcohol is prioritized due to its overwhelming association with the chronic form of the disease. * **Option C (Incorrect):** While hypertriglyceridemia (specifically levels >1000 mg/dL) is a known cause of pancreatitis, the consumption of trans fatty acids alone is not a direct or common primary etiology. **NEET-PG High-Yield Pearls:** 1. **Acute Pancreatitis:** Most common cause is **Gallstones** (Biliary pancreatitis). 2. **Chronic Pancreatitis:** Most common cause is **Alcohol**. 3. **Iatrogenic Cause:** Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) is a high-yield cause to remember. 4. **Scoring Systems:** Remember the **Ranson Criteria** and **APACHE II** for assessing severity. 5. **Investigation of Choice:** **CECT** (Contrast-Enhanced Computed Tomography) is the gold standard for diagnosing necrosis and complications.

Practice by Chapter

Pancreatic Anatomy and Physiology

Practice Questions

Acute Pancreatitis

Practice Questions

Chronic Pancreatitis

Practice Questions

Pancreatic Pseudocysts

Practice Questions

Pancreatic Adenocarcinoma

Practice Questions

Cystic Neoplasms of Pancreas

Practice Questions

Neuroendocrine Tumors of Pancreas

Practice Questions

Pancreatic Trauma

Practice Questions

Pancreatectomy Techniques

Practice Questions

Whipple Procedure

Practice Questions

Pancreatic Anastomosis

Practice Questions

Complications of Pancreatic Surgery

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free